Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats

European Journal of Pharmacology

Volumn 322, Issue 2-3, 1997, Pages 123-127

  Collu, Maria ^b   Poggiu, Alessandra S ^b   Devoto, Paola ^b   Serra, Gino ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Antidepressant drug; Chronic treatment; Dopamine receptor; Fluoxetine; Mesolimbic dopamine system

Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; INTRAGASTRIC DRUG ADMINISTRATION; LOCOMOTION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; SENSITIZATION; STEREOTYPY;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR, ANIMAL; FLUOXETINE; MALE; MOTOR ACTIVITY; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; STEREOTYPED BEHAVIOR;

EID: 0030941643     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00006-X     Document Type: Article

References (21)

1. Arnt, J., J. Hyttel and K. Fredrickson Overø, 1984, Prolonged treatment with the specific 5HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions, Pol. J. Pharmacol. Pharm. 36, 221.
2. Ashby Jr., C.R., Y. Minabe, C. Ramachandran, R.E. Strecker and S.L. Dewey, 1995, The effect of acute and chronic administration of (±)FLX on spontaneously active midbrain dopamine neurons: an in vivo electrophysiological study, Proc. Soc. Neurosci. 21, 153.2.
3. Caldecott-Hazard, S., D.G. Morgan, F. DeLeon-Jones, D.H. Overstreet and D. Janowski, 1991, Clinical and biochemical aspects of depressive disorders. II. Transmitter/receptor theories, Synapse 9, 251.
4. Collu, M., L. Pani, G.L. Gessa and G. Serra, 1994, Chronic imipramine potentiates cocaine-induced CPP, Pol. J. Pharmacol. 46, 315.
5. Collu, M., A.S. Poggiu and G. Serra, 1996, Antidepressants sensitize the dopamine mesolimbic system mediating reward, Behav. Pharmacol. 7 (Suppl. 1), 18.
6. Creese, I. and S.D. Iversen, 1975, The pharmacological and anatomical substrates of the amphetamine response in the rat, Brain Res. 83, 419.
7. 1 receptor agonists in the behavioural despair animal model of depression, Eur. J. Pharmacol. 262, 107.
8. De Montis, G., P. Devoto, G.L. Gessa, D. Meloni, A. Porcella, P. Saba, G. Serra and A. Tagliamonte, 1989, Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants, Eur. J. Pharmacol. 180, 31.
9. Fibiger, H.C., 1993, Mesolimbic dopamine: an analysis of its role in motivated behaviour, Semin. Neurosci. 5, 321.
10. Gambarana, C., O. Ghiglieri, I. Taddei, A. Tagliamonte and M.G. De Montis, 1995, Imipramine and fluoxetine prevent the stress-induced escape deficits in rats through a distinct mechanism of action, Behav. Pharmacol. 6, 66.
11. Gessa, G.L., L. Pani, G. Serra and W. Fratta, 1995, Animal models of mania, Adv. Biochem. Psychopharmacol. 49, 43.
12. Gram, L.F., 1994, Fluoxetine, New Engl. J. Med. 331, 1354.
13. 3H]SCh 23390 binding sites in the rat striatum and limbic system, Eur. J. Pharmacol. 139, 163.
14. 2 receptors in the rat brain, Eur. J. Pharmacol. 304, 49.
15. Martin-Iverson, M.T., J.-F. Leclere and H.C. Fibiger, 1983, Cholinergic-dopaminergic interactions and the mechanism of action of antidepressants, Eur. J. Pharmacol. 94, 193.
16. 1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants, Brain Res. 527, 234.
17. Serra, G., M. Collu, P.S. D'Aquila and G.L. Gessa, 1992, Role of the mesolimbic dopamine system in the mechanism of action of antidepressants, Pharmacol. Toxicol. 71 (Suppl. 1), 72.
18. Simon, B.B. and J.B. Appel, 1995, Dopaminergic and serotonergic properties of FLX, Proc. Soc. Neurosci. 21, 445.2.
19. Spyraki, C. and H.C. Fibiger, 1981, Sensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine, Eur. J. Pharmacol. 74, 195.
20. 3 receptors mediate FLX but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex, Psychopharmacology 119, 15.
21. Willner, P., 1995, Animal models of depression, Adv. Biochem. Psychopharmacol. 49, 19.